Literature DB >> 31410782

Consolidating the Role of TDP2 Mutations in Recessive Spinocerebellar Ataxia Associated with Pediatric Onset Drug Resistant Epilepsy and Intellectual Disability (SCAR23).

Claudia Ciaccio1, Raffaele Castello2, Silvia Esposito3, Michele Pinelli2,4, Vincenzo Nigro2,5, Giorgio Casari2,6, Luisa Chiapparini7, Chiara Pantaleoni3, Stefano D'Arrigo3.   

Abstract

Spinocerebellar Ataxia 23 (SCAR23) is a newly described condition caused by mutations in TDP2 gene. To date, only four patients from two families have been reported, all carrying the same homozygous mutation. We describe a fifth patient, carrying a novel mutation in the same gene, thus confirming the role of TDP2 mutations in determining the disease and defining the main features SCAR23: pediatric onset ataxia and drug-resistant epilepsy and intellectual disability. We further show the clinical presentation which is associated with the neuroradiological evidence of progressive cerebellar atrophy, giving the evidence that SCAR23 can be classified as a degenerative condition.

Entities:  

Keywords:  Cerebellar atrophy; Pediatric ataxia; SCAR23; Spinocerebellar ataxia; TDP2

Mesh:

Substances:

Year:  2019        PMID: 31410782     DOI: 10.1007/s12311-019-01069-7

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  4 in total

1.  TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function.

Authors:  Fernando Gómez-Herreros; Janneke H M Schuurs-Hoeijmakers; Mark McCormack; Marie T Greally; Stuart Rulten; Rocío Romero-Granados; Timothy J Counihan; Elijah Chaila; Judith Conroy; Sean Ennis; Norman Delanty; Felipe Cortés-Ledesma; Arjan P M de Brouwer; Gianpiero L Cavalleri; Sherif F El-Khamisy; Bert B A de Vries; Keith W Caldecott
Journal:  Nat Genet       Date:  2014-03-23       Impact factor: 38.330

2.  VarGenius executes cohort-level DNA-seq variant calling and annotation and allows to manage the resulting data through a PostgreSQL database.

Authors:  F Musacchia; A Ciolfi; M Mutarelli; A Bruselles; R Castello; M Pinelli; S Basu; S Banfi; G Casari; M Tartaglia; V Nigro
Journal:  BMC Bioinformatics       Date:  2018-12-12       Impact factor: 3.169

3.  TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo.

Authors:  Fernando Gómez-Herreros; Rocío Romero-Granados; Zhihong Zeng; Alejandro Alvarez-Quilón; Cristina Quintero; Limei Ju; Lieve Umans; Liesbeth Vermeire; Danny Huylebroeck; Keith W Caldecott; Felipe Cortés-Ledesma
Journal:  PLoS Genet       Date:  2013-03-07       Impact factor: 5.917

4.  Confirming TDP2 mutation in spinocerebellar ataxia autosomal recessive 23 (SCAR23).

Authors:  Guido Zagnoli-Vieira; Francesco Bruni; Kyle Thompson; Langping He; Sarah Walker; Arjan P M de Brouwer; Robert W Taylor; Dmitriy Niyazov; Keith W Caldecott
Journal:  Neurol Genet       Date:  2018-08-01
  4 in total
  4 in total

Review 1.  Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution.

Authors:  Amanda A Riccio; Matthew J Schellenberg; R Scott Williams
Journal:  Cell Mol Life Sci       Date:  2019-11-15       Impact factor: 9.261

Review 2.  Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC).

Authors:  Yilun Sun; Sourav Saha; Wenjie Wang; Liton Kumar Saha; Shar-Yin Naomi Huang; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2020-03-07

Review 3.  Next-Generation Sequencing Technologies and Neurogenetic Diseases.

Authors:  Hui Sun; Xiao-Rong Shen; Zi-Bing Fang; Zong-Zhi Jiang; Xiao-Jing Wei; Zi-Yi Wang; Xue-Fan Yu
Journal:  Life (Basel)       Date:  2021-04-19

Review 4.  Topoisomerase-Mediated DNA Damage in Neurological Disorders.

Authors:  Morgan Crewe; Ram Madabhushi
Journal:  Front Aging Neurosci       Date:  2021-11-25       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.